Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk

Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk

Aim: To clarify the alternation of gene expression responsible for resistance of Adriamycin (ADR) in rats, in addition to investigation of a novel promising drug-delivery system using titanium dioxide nanoparticles loaded with ADR (TiO2-ADR). Method: Breast cancer was induced in female Sprague-Dawle...

Full description

Saved in:
Bibliographic Details
Main Authors: Rehab M Abdel-Megeed, Abdel-Hamid Z Abdel-Hamid, Mai O Kadry
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Future Science OA
Subjects:
ABCA1
Adriamycin
breast cancer
C-myc
drug resistance
titanium dioxide nanoparticles
Online Access:https://www.tandfonline.com/doi/10.2144/fsoa-2023-0107
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.2144/fsoa-2023-0107

Similar Items